Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Lenz Therapeutics and Arrotex Pharmaceuticals announced that they have reached an exclusive licensing and commercialization agreement for Vizz™ in the Australian and New Zealand markets.

Lenz Therapeutics and Arrotex Pharmaceuticals announced that they have reached an exclusive licensing and commercialization agreement for Vizz™ in the Australian and New Zealand markets.

老虎证券老虎证券2026/06/24 12:45
Show original
The signing of this agreement marks that the two companies will jointly advance the commercialization of Vizz™ in the aforementioned regions.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Singapore data center operator DayOne (DODC.US) applies for US listing, valuation may reach 20 billions

Data center operator DayOne Data Centers filed an F-1 registration statement with the U.S. Securities and Exchange Commission (SEC) on Monday, planning to launch an initial public offering of American Depositary Shares (ADS) on the Nasdaq Stock Market.

智通财经•2026/10/06 02:17